Aquestive Therapeutics, Inc. Accounts Receivable, Allowance for Credit Loss, Writeoff
Aquestive Therapeutics, Inc. (AQST) reported Accounts Receivable, Allowance for Credit Loss, Writeoff of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-05.
Discontinued › Notes › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs · last filed 2024-03-05
- Aquestive Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2023-12-31 was $0.00.
- Aquestive Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2023-09-30 was $0.00.
- Aquestive Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2023-06-30 was $0.00.
- Aquestive Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2023-03-31 was $0.00.
- Aquestive Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2023 was $0.00.
- Aquestive Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2022 was $0.00.
- Aquestive Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2020 was $282.00K.
- Aquestive Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
| Period end | Accounts Receivable, Allowance for Credit Loss, Writeoff 3 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 6 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 9 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $0.00 derived: sum of 2 quarters · filed 2024-03-05 | $0.00 derived: sum of 3 quarters · filed 2024-03-05 | $0.00 10-K · filed 2024-03-05 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $0.00 derived: sum of 2 quarters · filed 2023-11-06 | $0.00 10-Q · filed 2023-11-06 | $0.00 derived: sum of 4 quarters · filed 2024-03-05 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | $0.00 derived: sum of 3 quarters · filed 2024-03-05 | $0.00 derived: sum of 4 quarters · filed 2024-03-05 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-02 | $0.00 derived: sum of 2 quarters · filed 2024-03-05 | $0.00 derived: sum of 3 quarters · filed 2024-03-05 | $0.00 derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $0.00 derived: sum of 2 quarters · filed 2024-03-05 | $0.00 derived: sum of 3 quarters · filed 2024-03-05 | $0.00 10-K · filed 2024-03-05 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $0.00 derived: sum of 2 quarters · filed 2022-11-01 | $0.00 10-Q · filed 2022-11-01 | $0.00 derived: sum of 4 quarters · filed 2022-11-01 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $0.00 10-Q · filed 2022-08-02 | $0.00 derived: sum of 3 quarters · filed 2022-11-01 | $0.00 derived: sum of 4 quarters · filed 2022-11-01 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-01 | $0.00 derived: sum of 3 quarters · filed 2022-11-01 | $0.00 derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2022-11-01 | $0.00 derived: sum of 2 quarters · filed 2022-11-01 | $0.00 derived: sum of 3 quarters · filed 2022-11-01 | $0.00 10-Q · filed 2022-11-01 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-02 | $0.00 derived: sum of 2 quarters · filed 2022-08-02 | $0.00 10-Q · filed 2022-08-02 | $282.00K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-04 | $0.00 10-Q · filed 2022-05-04 | $282.00K derived: sum of 3 quarters · filed 2022-05-04 | $282.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-04 | $282.00K derived: sum of 2 quarters · filed 2022-03-08 | $282.00K derived: sum of 3 quarters · filed 2022-03-08 | |
| 2020-12-31 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $282.00K derived: sum of 2 quarters · filed 2022-03-08 | $282.00K 10-K · filed 2022-03-08 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $0.00 10-Q · filed 2020-11-04 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-04 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $0.00 derived: sum of 2 quarters · filed 2021-03-09 | $0.00 derived: sum of 3 quarters · filed 2021-03-09 | $0.00 10-K · filed 2021-03-09 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | -$3.00K derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | -$3.00K derived: sum of 3 quarters · filed 2020-03-11 | $19.00K derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 | -$3.00K derived: sum of 2 quarters · filed 2020-03-11 | $19.00K derived: sum of 3 quarters · filed 2020-03-11 | |
| 2018-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $19.00K derived: sum of 2 quarters · filed 2020-03-11 | $50.00K 10-K · filed 2020-03-11 | |
| 2018-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $53.00K 10-Q · filed 2018-11-06 | ||
| 2018-06-30 | $31.00K 10-Q · filed 2018-09-04 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |